These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 14960885)

  • 1. Genetic diversity in the human major histocompatibility complex: lessons for vaccination approaches to HIV infection.
    Mehra NK; Kaur G; Jaini R
    Community Genet; 2002; 5(3):162-6. PubMed ID: 14960885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MHC-based vaccination approaches: progress and perspectives.
    Mehra NK; Kaur G
    Expert Rev Mol Med; 2003 Feb; 5(7):1-17. PubMed ID: 14987410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of susceptibility to type 1 diabetes with special reference to the Indian population.
    Mehra NK; Kumar N; Kaur G; Kanga U; Tandon N
    Indian J Med Res; 2007 Mar; 125(3):321-44. PubMed ID: 17496359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA genetics and disease with particular reference to Type 1 diabetes and HIV infection in Asian Indians.
    Mehra N; Kaur G
    Expert Rev Clin Immunol; 2006 Nov; 2(6):901-13. PubMed ID: 20476978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune-associated HLA-B8-DR3 haplotypes in Asian Indians are unique in C4 complement gene copy numbers and HSP-2 1267A/G.
    Kaur G; Kumar N; Szilagyi A; Blasko B; Fust G; Rajczy K; Pozsonyi E; Hosso A; Petranyi G; Tandon N; Mehra N
    Hum Immunol; 2008 Sep; 69(9):580-7. PubMed ID: 18657583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allotyping human complement factor B in Asian Indian type 1 diabetic patients.
    Kumar N; Kaur G; Tandon N; Mehra NK
    Tissue Antigens; 2008 Dec; 72(6):517-24. PubMed ID: 19000152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The major histocompatibility complex: the value of extended haplotypes in the analysis of associated immune diseases and disorders.
    Kruskall MS
    Yale J Biol Med; 1990; 63(5):477-86. PubMed ID: 2293506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of HLA-DR alleles and complotypes through the ethnic barrier in systemic lupus erythematosus in Mexicans.
    Granados J; Vargas-Alarcón G; Andrade F; Melín-Aldana H; Alcocer-Varela J; Alarcón-Segovia D
    Lupus; 1996 Jun; 5(3):184-9. PubMed ID: 8803888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class I haplotype diversity is consistent with selection for frequent existing haplotypes.
    Alter I; Gragert L; Fingerson S; Maiers M; Louzoun Y
    PLoS Comput Biol; 2017 Aug; 13(8):e1005693. PubMed ID: 28846675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linkage disequilibrium of HLA-DR3 and HLA-DR4 with HLA-B alleles in Mexican patients with rheumatoid arthritis.
    Avila-Portillo LM; Vargas-Alarcón G; Andrade F; Alarcón-Segovia D; Granados J
    Clin Exp Rheumatol; 1994; 12(5):497-502. PubMed ID: 7842529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 1 diabetes in the Spanish population: additional factors to class II HLA-DR3 and -DR4.
    Urcelay E; Santiago JL; de la Calle H; Martínez A; Méndez J; Ibarra JM; Maluenda C; Fernández-Arquero M; de la Concha EG
    BMC Genomics; 2005 Apr; 6():56. PubMed ID: 15842729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF2, a polymorphism of the tumour necrosis-alpha gene promoter, is a component of the celiac disease major histocompatibility complex haplotype.
    McManus R; Wilson AG; Mansfield J; Weir DG; Duff GW; Kelleher D
    Eur J Immunol; 1996 Sep; 26(9):2113-8. PubMed ID: 8814255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic evaluation of HLA-DR3+ haplotypes associated with type 1 diabetes.
    Kumar N; Kaur G; Tandon N; Kanga U; Mehra NK
    Ann N Y Acad Sci; 2013 Apr; 1283():91-6. PubMed ID: 23387390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linkage disequilibrium between human leukocyte antigen (HLA) class II and HLA-G--possible implications for human reproduction and autoimmune disease.
    Hviid TV; Christiansen OB
    Hum Immunol; 2005 Jun; 66(6):688-99. PubMed ID: 15993714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic fixity in the human major histocompatibility complex and block size diversity in the class I region including HLA-E.
    Romero V; Larsen CE; Duke-Cohan JS; Fox EA; Romero T; Clavijo OP; Fici DA; Husain Z; Almeciga I; Alford DR; Awdeh ZL; Zuñiga J; El-Dahdah L; Alper CA; Yunis EJ
    BMC Genet; 2007 Apr; 8():14. PubMed ID: 17430593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-associated susceptibility to type 1 diabetes is caused by linkage disequilibrium with HLA-DR3 haplotypes.
    Kumar N; Kaur G; Tandon N; Mehra N
    Hum Immunol; 2012 May; 73(5):566-73. PubMed ID: 22366579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenetic basis of HIV-1 infection, transmission and disease progression.
    Singh P; Kaur G; Sharma G; Mehra NK
    Vaccine; 2008 Jun; 26(24):2966-80. PubMed ID: 18321617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The haplotype block, NFKBIL1-ATP6V1G2-BAT1-MICB-MICA, within the class III-class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus-associated dilated cardiomyopathy.
    Shichi D; Kikkawa EF; Ota M; Katsuyama Y; Kimura A; Matsumori A; Kulski JK; Naruse TK; Inoko H
    Tissue Antigens; 2005 Sep; 66(3):200-8. PubMed ID: 16101831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with HLA-DR3.
    Price P; Santoso L; Mastaglia F; Garlepp M; Kok CC; Allcock R; Laing N
    Tissue Antigens; 2004 Nov; 64(5):575-80. PubMed ID: 15496200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.